Mostrar el registro sencillo del ítem

dc.contributor.authorRoyo-Bordonada, Miguel Angel 
dc.contributor.authorArmario, Pedro
dc.contributor.authorLobos Bejarano, José María
dc.contributor.authorPedro-Botet, Juan
dc.contributor.authorVillar Alvarez, Fernando 
dc.contributor.authorElosua, Roberto
dc.contributor.authorBrotons Cuixart, Carlos
dc.contributor.authorCortés, Olga
dc.contributor.authorSerrano, Benilde
dc.contributor.authorCamafort Babkowski, Miguel
dc.contributor.authorGil Núñez, Antonio
dc.contributor.authorPérez, Antonio
dc.contributor.authorMaiques, Antonio
dc.contributor.authorde Santiago Nocito, Ana
dc.contributor.authorde Castro, Almudena
dc.contributor.authorAlegría, Eduardo
dc.contributor.authorBaeza, Ciro
dc.contributor.authorYuste-Herranz, Maria Eloisa
dc.contributor.authorSans, Susana
dc.contributor.authorCampos, Pilar
dc.date.accessioned2020-03-26T09:24:38Z
dc.date.available2020-03-26T09:24:38Z
dc.date.issued2017
dc.identifier.citationGac Sanit. 2017 May - Jun;31(3):255-268.es_ES
dc.identifier.issn0213-9111es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9339
dc.description.abstractThe VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk. The guidelines highlight disease specific interventions, and conditions as women, young people and ethnic minorities. Screening for subclinical atherosclerosis with noninvasive imaging techniques is not recommended. The guidelines distinguish four risk levels (very high, high, moderate and low) with therapeutic objectives for lipid control according to risk. Diabetes mellitus confers a high risk, except for subjects with type 2 diabetes with less than <10 years of evolution, without other risk factors or complications, or type 1 diabetes of short evolution without complications. The decision to start pharmacological treatment of arterial hypertension will depend on the blood pressure level and the cardiovascular risk, taking into account the lesion of target organs. The guidelines don't recommend antiplatelet drugs in primary prevention because of the increased bleeding risk. The low adherence to the medication requires simplified therapeutic regimes and to identify and combat its causes. The guidelines highlight the responsibility of health professionals to take an active role in advocating evidence-based interventions at the population level, and propose effective interventions, at individual and population level, to promote a healthy diet, the practice of physical activity, the cessation of smoking and the protection against alcohol abuse.es_ES
dc.language.isospaes_ES
dc.publisherElsevier es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAlcohol drinkinges_ES
dc.subjectCardiovascular diseaseses_ES
dc.subjectCholesteroles_ES
dc.subjectColesteroles_ES
dc.subjectConsumo de alcoholes_ES
dc.subjectDiabetes mellituses_ES
dc.subjectEnfermedades cardiovasculareses_ES
dc.subjectGrasas transes_ES
dc.subjectGuías de práctica clínicaes_ES
dc.subjectHipertensión arteriales_ES
dc.subjectHypertensiones_ES
dc.subjectPractice Guidelines [Publication Type]es_ES
dc.subjectPrevención y controles_ES
dc.subjectPrevention and controles_ES
dc.subjectTabacoes_ES
dc.subjectTobaccoes_ES
dc.subjectTrans fatty acidses_ES
dc.subject.meshAge Factors es_ES
dc.subject.meshBiomarkers es_ES
dc.subject.meshCardiovascular Diseases es_ES
dc.subject.meshEurope es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHealth Promotion es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMale es_ES
dc.subject.meshMass Screening es_ES
dc.subject.meshPatient Compliance es_ES
dc.subject.meshPhysician's Role es_ES
dc.subject.meshRisk Factors es_ES
dc.subject.meshSpain es_ES
dc.subject.meshLife Style es_ES
dc.subject.meshPractice Guidelines as Topic es_ES
dc.subject.meshRisk Assessment es_ES
dc.titleAdaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínicaes_ES
dc.title.alternativeSpanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practicees_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID28292529es_ES
dc.format.volume31es_ES
dc.format.number3es_ES
dc.format.page255-268es_ES
dc.identifier.doi10.1016/j.gaceta.2016.12.007es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1578-1283es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.gaceta.2016.12.007es_ES
dc.identifier.journalGaceta sanitariaes_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidades_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional